fr   en
Clinical Studies
Phase :    
Announcement :   
Select a Pharma :
Select a product :
Select a disease :
Choose date:
[<<]      «      47   |   48   |   49   |   50   |   51   |   52   |   53   |   54   |   55   |   56   |   57   
Date Phase Anouncement Biotech Pharma Product Disease Country Other
2006-02-24 I Launch IDM Pharma (France)   Junovan® (a synthetic derivative of muramyl pentapeptide) osteosarcoma   See details
2006-02-16 III Launch Imclone (USA) Merck KGaA (Germany) Erbitux® (cetuximab) squamous cell carcinoma of the head and neck international study See details
2006-02-16 III Launch Imclone (USA)   Erbitux® (cetuximab) metastatic colorectal cancer international study See details
2006-02-16 III Launch Imclone (USA) Merck KGaA (Germany) Erbitux® (cetuximab) non-small-cell lung cancer international study See details
2006-01-09 II Launch Gilead Sciences (USA)   JTK-303 or GS 9137 (HIV integrase inhibitor) AIDS   See details
[<<]      «      47   |   48   |   49   |   50   |   51   |   52   |   53   |   54   |   55   |   56   |   57